Menu
  • Join
  • Login
  • Contact
 

Search abstracts


PHARMACOVIGILANCE ANALYSIS OF STATIN-ASSOCIATED MUSCLE SYMPTOMS

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: CERDá IñESTA, Judith (University of Malta, Department of Pharmacy, Malta)
  • Co-author(s): Judith Cerdá Iñesta: Department of Pharmacy, University of Malta, Msida, Malta;, Malta Medicines Authority, Malta Life Sciences Park, San Ġwann, Malta
    Francesca Wirth: Department of Pharmacy, University of Malta, Msida, Malta
    Anthony Serracino-Inglott: Department of Pharmacy, University of Malta, Msida, Malta;, Malta Medicines Authority, Malta Life Sciences Park, San Ġwann, Malta
  • Abstract:

    Background

    Muscle symptoms are clinically-relevant side-effects of statin therapy. Incidence of statin-associated muscle symptoms (SAMS), including myalgia, myopathy and rhabdomyolysis, varies with the different statins.

    Methods

    ADRs reports of myalgia, myopathy and rhabdomyolysis with simvastatin, atorvastatin and rosuvastatin from 28 European Union

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 21 September 2019

FIP Congresses